TAmiRNA, Evercyte and Phoenestra, three leading biotech companies, will present their cutting-edge work in for production and characterization of clinical-grade extracellular vesicles (EVs) at the upcoming shared Annual Meeting of the Austrian and Czechia Societies for Extracellular Vesicles (ASEV & CzeSEV) on 16th/17th September in Vienna.
As esteemed ASEV members, TAmiRNA and Evercyte are well-known participants at these meetings and this year will take the spotlight as Platinum Sponsors. They will be joined by Phoenestra in this sponsorship as part of the EVscale™ Partnership, showcasing their joint capabilities and innovation in EV research and development.
Don’t miss this opportunity to explore TAmiRNA’s latest advancements regarding transcriptomic characterization of EVs.
Meet us at the ASEV or reach out to info@tamirna.com to discuss our latest developments and how TAmiRNA’s services for EV characterization can assist your business!
TAmiRNA CEO Dr. Matthias Hackl
